Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 5, 2011, Pages 1049-1055

  Wautier, M P ^a,b,c   Heron E ^d   Picot, J ^a,b,c   Colin, Y ^a,b,c   Hermine, O ^e   Wautier, J L ^a,b,f  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^d CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Adhesion molecules; Endothelial cell; Phosphatidylserine; Red blood cell; Retinal vessels

Indexed keywords

CELL ADHESION MOLECULE; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

ADULT; AGED; ARTICLE; BLOOD VISCOSITY; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ERYTHROCYTE; ERYTHROCYTE ADHESIVENESS; ERYTHROCYTE AGGREGATION; FEMALE; HUMAN; HUMAN CELL; LABORATORY TEST; MALE; PATHOPHYSIOLOGY; POLYCYTHEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA ARTERY OCCLUSION; SICKLE CELL;

ADULT; AGED; ANNEXIN A5; CELL ADHESION; ERYTHROCYTE AGGREGATION; ERYTHROCYTES; FEMALE; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLSERINES; RETINAL ARTERY; RETINAL VEIN OCCLUSION; RETINAL VESSELS;

EID: 79955646067     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04251.x     Document Type: Article

References (32)

1. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996; 114: 1243-7.
2. Rogers S, McIntosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010; 117: 313-9.
3. Cahill MT, Fekrat S. Arteriovenous sheathotomy for branch retinal vein occlusion. Ophthalmol Clin North Am 2002; 15: 417-23.
4. Williamson TH. Central retinal vein occlusion: what's the story? Br J Ophthalmol 1997; 81: 698-704.
5. Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost 2010; 8: 1886-94.
6. Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP, Poli D, Pepe G, Abbate R, Prisco D. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001; 86: 772-6.
7. Yasuda M, Kiyohara Y, Arakawa S, Hata Y, Yonemoto K, Doi Y, Iida M, Ishibashi T. Prevalence and systemic risk factors for retinal vein occlusion in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 2010; 51: 3205-9.
8. Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, Yannuzzi LA. Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the eye disease case-control study. Ophthalmology 1998; 105: 765-71.
9. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005; 93: 1021-6.
10. Chabanel A, Glacet-Bernard A, Lelong F, Taccoen A, Coscas G, Samama MM. Increased red blood cell aggregation in retinal vein occlusion. Br J Haematol 1990; 75: 127-31.
11. Arend O, Remky A, Jung F, Kiesewetter H, Reim M, Wolf S. Role of rheologic factors in patients with acute central retinal vein occlusion. Ophthalmology 1996; 103: 80-6.
12. Williamson TH, Rumley A, Lowe GD. Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 1996; 80: 203-8.
13. Sofi F, Mannini L, Marcucci R, Bolli P, Sodi A, Giambene B, Menchini U, Gensini GF, Abbate R, Prisco D. Role of haemorheological factors in patients with retinal vein occlusion. Thromb Haemost 2007; 98: 1215-9.
14. Yedgar S, Kaul DK, Barshtein G. RBC adhesion to vascular endothelial cells: more potent than RBC aggregation in inducing circulatory disorders. Microcirculation 2008; 15: 581-3.
15. Heron E, Marzac C, Feldman-Billard S, Girmens JF, Paques M, Delarue R, Piette JC, Casadevall N, Hermine O. Endogenous erythroid colony formation in patients with retinal vein occlusion. Ophthalmology 2007; 114: 2155-61.
16. Wautier MP, El Nemer W, Gane P, Rain JD, Cartron JP, Colin Y, Le Van Kim C, Wautier JL. Increased adhesion to endothelial cells of erythrocytes from patients with polycythemia vera is mediated by laminin alpha5 chain and Lu/BCAM. Blood 2007; 110: 894-901.
17. Wautier MP, Boulanger E, Guillausseau PJ, Massin P, Wautier JL. AGEs, macrophage colony stimulating factor and vascular adhesion molecule blood levels are increased in patients with diabetic microangiopathy. Thromb Haemost 2004; 91: 879-85.
18. Hebbel RP, Boogaerts MA, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N Engl J Med 1980; 302: 992-5.
19. Lelkens CC, Noorman F, Koning JG, Truijens-de Lange R, Stekkinger PS, Bakker JC, Lagerberg JW, Brand A, Verhoeven AJ. Stability after thawing of RBCs frozen with the high- and low-glycerol method. Transfusion 2003; 43: 157-64.
20. Wautier JL, Paton RC, Wautier MP, Pintigny D, Abadie E, Passa P, Caen JP. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 1981; 305: 237-42.
21. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH. Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently labeled annexin V. Blood 1996; 87: 1179-87.
22. Wautier MP, Khodabandehlou T, Le Devehat C, Wautier JL. Modulation of RAGE expression influences the adhesion of red blood cells from diabetic patients. Clin Hemorheol Microcirc 2006; 35: 379-86.
23. Bratton DL, Henson PM. Apoptotic cell recognition: will the real phosphatidylserine receptor(s) please stand up? Curr Biol 2008; 18: R76-9.
24. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996; 88: 1873-80.
25. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS. Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003; 101: 4625-7.
26. Barber LA, Palascak MB, Joiner CH, Franco RS. Aminophospholipid translocase and phospholipid scramblase activities in sickle erythrocyte subpopulations. Br J Haematol 2009; 146: 447-55.
27. Soupene E, Kuypers FA. Identification of an erythroid ATP-dependent aminophospholipid transporter. Br J Haematol 2006; 133: 436-8.
28. Wolfs JL, Comfurius P, Rasmussen JT, Keuren JF, Lindhout T, Zwaal RF, Bevers EM. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell Mol Life Sci 2005; 62: 1514-25.
29. Kuypers FA, Yuan J, Lewis RA, Snyder LM, Kiefer CR, Bunyaratvej A, Fucharoen S, Ma L, Styles L, de Jong K, Schrier SL. Membrane phospholipid asymmetry in human thalassemia. Blood 1998; 91: 3044-51.
30. Setty BN, Betal SG. Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes. Blood 2008; 111: 905-14.
31. El Nemer W, Wautier MP, Rahuel C, Gane P, Hermand P, Galacteros F, Wautier JL, Cartron JP, Colin Y, Le Van Kim C. Endothelial Lu/BCAM glycoproteins are novel ligands for red blood cell alpha4beta1 integrin: role in adhesion of sickle red blood cells to endothelial cells. Blood 2007; 109: 3544-51.
32. Bartolucci P, Chaar V, Picot J, Bachir D, Habibi A, Fauroux C, Galacteros F, Colin Y, Le Van Kim C, El Nemer W. Decreased sickle red blood cell adhesion to laminin by hydroxyurea is associated with inhibition of Lu/BCAM protein phosphorylation. Blood 2010; 116: 2152-9.